1604803
Ritonavir
United States Pharmacopeia (USP) Reference Standard
Manufacturer: Sigma Aldrich
CAS Number: 155213-67-5
Synonym(S): 1,3-Thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 200 MG | 1604803-200-MG | In Stock | ₹ 40,756.13 |
1604803 - 200 MG
In Stock
Quantity
1
Base Price: ₹ 40,756.13
GST (18%): ₹ 7,336.103
Total Price: ₹ 48,092.233
biological source
synthetic
grade
pharmaceutical primary standard
Agency
USP
vapor pressure
<0.0000001 kPa ( 25 °C)
API family
ritonavir
form
powder
packaging
pkg of 200 mg
manufacturer/tradename
USP
storage condition
protect from light
color
white to tan
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
eMolecules RITONAVIR | 155213-67-5 | MFCD00927142 | 5g | -- | ₹ 19,912.86 | ||
Ritonavir Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™ | -- | ₹ 14,035.30 | ||
Selleck Chemical LLC Ritonavir 10mg 155213-67-5 ABT-538, A 84538 | -- | ₹ 15,699.60 | ||
Sigma Aldrich Fine Chemicals Biosciences Ritonavir European Pharmacopoeia (EP) Reference Standard | 155213-67-5 | | -- | ₹ 24,531.07 | ||
Ritonavir | -- | ₹ 15,966.88 | ||
Ritonavir | -- | ₹ 21,401.03 | ||
Ritonavir for peak identification | -- | ₹ 15,966.88 | ||
Ritonavir | -- | ₹ 1,513.00 - ₹ 1,34,657.00 | ||
155213-67-5 | 2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)- | -- | ₹ 1,246.00 - ₹ 61,410.00 |
Related Products
Description
- General description: This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.[1]
- Application: Ritonavir USP reference standard suitable for use in specified USP compendial tests and assays.Also used to prepare standard, standard stock, identification, and standard working solution for assay, impurity analysis, and performance test according to the given below monographs of United States Pharmacopeia (USP):Lopinavir and Ritonavir Tablets [2]Ritonavir Tablets [3]Ritonavir [4]Lopinavir and Ritonavir Oral Solution [5]
- Analysis Note: These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.
- Other Notes: Sales restrictions may apply.
SAFETY INFORMATION
Pictograms
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable